ScanSource (SCSC) Q3 2026 earnings review
Sales Rebound, But High-Margin Segment Stumbles
ScanSource finally broke its streak of top-line sluggishness, delivering 8.8% YoY net sales growth in Q3. However, the quality of this revenue shift is concerning. The volume recovery was driven entirely by the lower-margin Specialty Technology Solutions (STS) segment, while the Intelisys & Advisory segment—management's touted future growth engine—unexpectedly shrank by 1.5%. As a result, both gross and adjusted EBITDA margins contracted. Despite the mixed operational quality, aggressive working capital management allowed the company to raise its FY26 free cash flow guidance to at least $90 million.
🐂 Bull Case
The core STS segment accelerated sharply to 9.2% YoY growth, driven by broad-based North American demand. This definitively ends the 'slower large deals' narrative that plagued the first half of the year.
ScanSource raised its FY26 Free Cash Flow guidance to at least $90M. The company generated $118.6M in FCF in the first nine months alone, easily funding the $71.4M in year-to-date share repurchases.
🐻 Bear Case
Gross margin dropped 25 bps YoY to 14.0%, and adjusted EBITDA margin fell 32 bps to 4.65%. The mix shift toward hardware and away from recurring revenue is pressuring profitability.
Intelisys & Advisory revenue declined 1.5% YoY, completely contradicting management's prior claims of 'double-digit new order growth' in the segment.
⚖️ Verdict: ⚪
Neutral. The return to solid top-line growth is a relief, but the margin compression and the contraction in the strategic Intelisys segment raise questions about the long-term earnings trajectory.
Key Themes
Intelisys Contraction Contradicts Growth Narrative
Reversing. For multiple quarters, management touted the Intelisys & Advisory segment as the high-margin future, explicitly citing 'double-digit new order growth' that would soon convert to billings. Q3 actuals broke that promise: segment revenue declined 1.5% YoY to $26.0M. Management blamed 'lower Resourcive sales,' but this directly contradicts the forward-looking growth narrative the company has relied on to justify heavy SG&A investments.
STS Segment Leads the Volume Rebound
Accelerating. The Specialty Technology Solutions (STS) segment surged 9.2% YoY to $740.8M. After struggling with delayed large deals earlier in the fiscal year, this quarter confirms those deployments are finally being realized across North America, providing a solid floor for total company revenues.
Recurring Revenue Mix Deteriorates
Decelerating. A central pillar of ScanSource's 3-year strategic goal is pushing recurring revenue to 50% of gross profit. In Q3, recurring revenue growth slowed to a crawl (+3.6% YoY vs +41% a year ago). Consequently, recurring revenue represented only 34.7% of total gross profit, down from 35.5% in the prior-year period. This mix shift directly penalized gross and operating margins.
Brazil Macro Environment Turns into a Tailwind
Reversing. For the past year, Brazil was a significant drag on ScanSource's top line due to severe FX headwinds and cautious enterprise spending. In Q3, Brazil net sales surged 18.0% YoY to $56.5M. This stabilization in a historically volatile macro environment provides a crucial buffer for the core hardware distribution business.
Converged Communications Restructuring
Stable. The company officially launched its 'Converged Communications CX Team,' formally merging ScanSource Specialty hardware and Intelisys cloud services into a single go-to-market motion. While the strategic logic of bundling UCaaS/CCaaS with physical hardware makes sense, the immediate decline in Intelisys sales suggests organizational friction during the rollout.
Profitability Squeezed Across the Board
Decelerating. Gross margin compressed 25 bps YoY to 14.0%, and Adjusted EBITDA margin contracted 32 bps to 4.65%. Even with an 8.8% jump in sales, GAAP Net Income dropped 3.1% YoY to $16.9M. The company is currently sacrificing margin percentage to chase hardware volume.
Other KPIs
A major bright spot. Up significantly from $98.9M in the prior-year nine-month period. Management's tight grip on working capital—specifically maintaining disciplined accounts receivable and inventory levels during a growth quarter—has allowed them to fully fund $71.4M in share repurchases without stretching the balance sheet.
Accelerating. Up 9.3% YoY from $0.86. The aggressive share repurchase program (reducing the diluted share count to 21.57 million from 23.60 million a year ago) successfully manufactured EPS growth despite flat Non-GAAP net income ($20.4M vs $20.3M).
Guidance
Stable. Management reiterated the full-year target. Given the strong Q3 beat, maintaining the range implies expectations for flat-to-slight deceleration in Q4 to hit the midpoint.
Stable. Also reiterated. Through nine months, they have generated $105.4M in Adjusted EBITDA, implying Q4 needs to deliver roughly $34.6M to $44.6M—a highly achievable run rate based on historical Q4 seasonality.
Accelerating. Raised from 'At least $80 million'. Interestingly, the company has already generated $118.6M YTD, which implies management expects a cash outflow in Q4, likely due to a seasonal buildup in accounts receivable or inventory.
Key Questions
Intelisys Disconnect
For three quarters, we heard about 'double-digit new order growth' in Intelisys that would soon convert to revenue. This quarter, revenue shrank 1.5%. Was the prior order growth overstated, or are implementations facing severe delays?
Resourcive Weakness
You specifically called out lower Resourcive sales as a drag on Intelisys. Is this a one-time execution issue post-acquisition, or structural weakness in the technology advisory market?
Margin Floor
With gross margins dropping to 14.0% and adjusted EBITDA margins down to 4.65%, what is the expected margin floor if the mix continues to heavily favor hardware over recurring revenue?